CA2477105A1 - Ambroxol for the treatment of painful conditions in the mouth and pharyngeal cavity - Google Patents
Ambroxol for the treatment of painful conditions in the mouth and pharyngeal cavity Download PDFInfo
- Publication number
- CA2477105A1 CA2477105A1 CA002477105A CA2477105A CA2477105A1 CA 2477105 A1 CA2477105 A1 CA 2477105A1 CA 002477105 A CA002477105 A CA 002477105A CA 2477105 A CA2477105 A CA 2477105A CA 2477105 A1 CA2477105 A1 CA 2477105A1
- Authority
- CA
- Canada
- Prior art keywords
- oral
- ambroxol
- pharmaceutical composition
- pain
- pharyngeal cavity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Pulmonology (AREA)
- Neurosurgery (AREA)
- Nutrition Science (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Molecular Biology (AREA)
- Rheumatology (AREA)
- Otolaryngology (AREA)
- Communicable Diseases (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Physiology (AREA)
- Oncology (AREA)
- Emergency Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10208313.4 | 2002-02-27 | ||
DE10208313A DE10208313A1 (de) | 2002-02-27 | 2002-02-27 | Ambroxol für die Behandlung von schmerzhaften Zuständen im Mund und Rachenraum |
PCT/EP2003/001886 WO2003072094A1 (de) | 2002-02-27 | 2003-02-25 | Ambroxol für die behandlung von schmerzhaften zuständen im mund und rachenraum |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2477105A1 true CA2477105A1 (en) | 2003-09-04 |
Family
ID=27740434
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002477105A Abandoned CA2477105A1 (en) | 2002-02-27 | 2003-02-25 | Ambroxol for the treatment of painful conditions in the mouth and pharyngeal cavity |
Country Status (21)
Country | Link |
---|---|
EP (1) | EP1480626A1 (ru) |
JP (1) | JP2005518435A (ru) |
KR (1) | KR20040084944A (ru) |
CN (1) | CN1638749A (ru) |
AR (1) | AR038698A1 (ru) |
AU (1) | AU2003210345B2 (ru) |
BR (1) | BR0308038A (ru) |
CA (1) | CA2477105A1 (ru) |
DE (1) | DE10208313A1 (ru) |
EC (1) | ECSP045242A (ru) |
IS (1) | IS7417A (ru) |
MX (1) | MXPA04008220A (ru) |
MY (1) | MY144781A (ru) |
PE (1) | PE20030830A1 (ru) |
PL (1) | PL371584A1 (ru) |
RU (1) | RU2311176C2 (ru) |
TW (1) | TW200306804A (ru) |
UA (1) | UA86741C2 (ru) |
UY (1) | UY27679A1 (ru) |
WO (1) | WO2003072094A1 (ru) |
ZA (1) | ZA200405635B (ru) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11759439B2 (en) | 2017-06-16 | 2023-09-19 | Kai-Uwe KERN | Bromhexine for the treatment of pain |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10332486A1 (de) * | 2003-07-16 | 2005-02-10 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Ambroxol für die Behandlung akuter Schmerzen |
JP2005120063A (ja) * | 2003-10-14 | 2005-05-12 | Boehringer Ingelheim Pharma Gmbh & Co Kg | 咽頭における炎症の治療のためのアンブロキソール |
ITMI20032462A1 (it) * | 2003-12-16 | 2005-06-17 | Advance Holdings Ltd | Metodo per preparare una caramella contenente ambroxolo e la caramella cosi' ottenuta |
DE102004021992A1 (de) * | 2004-05-03 | 2005-11-24 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Topische Zubereitung enthaltend Ambroxol |
JP2007084471A (ja) * | 2005-09-21 | 2007-04-05 | Sunstar Inc | 口腔用組成物および口腔用製品の選択方法 |
EP2015761A4 (en) * | 2006-03-29 | 2009-07-29 | Naveh Pharma 1996 Ltd | METHODS AND COMPOSITION FOR THE TREATMENT OF THROAT SORE |
JP5765934B2 (ja) * | 2009-12-28 | 2015-08-19 | サンスター株式会社 | 口腔用組成物 |
JP6171683B2 (ja) * | 2012-08-03 | 2017-08-02 | 大正製薬株式会社 | 固形製剤 |
CN105769908B (zh) * | 2016-05-06 | 2019-03-01 | 湖北凤凰白云山药业有限公司 | 一种化痰止咳的药物及其制备方法 |
US10265280B2 (en) | 2016-11-14 | 2019-04-23 | Mingwu Wang | Formulations for the treatment of ocular surface diseases and related methods |
CN106727621A (zh) * | 2016-11-22 | 2017-05-31 | 郑州仁宏医药科技有限公司 | 一种治疗牙痛的西药散剂 |
JP6844394B2 (ja) * | 2017-04-14 | 2021-03-17 | 大正製薬株式会社 | 固形組成物 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0138020B1 (de) * | 1983-09-17 | 1992-06-03 | Dr. Karl Thomae GmbH | Antiadhäsive Prophylactica und Arzneimittel enthaltend ein sekretolytisch wirksames Benzylaminderivat |
DE3445226A1 (de) * | 1983-12-14 | 1985-08-01 | Reifenrath, Rainer Richard Otto, Dr.med., 7920 Heidenheim | Pharmazeutisches erzeugnis zur behandlung und prophylaxe von infektionen sowie von husten und obstruktiven atemwegserkrankungen |
US5122540A (en) * | 1986-02-28 | 1992-06-16 | W. Keith R. Watson | Method and composition for treating warts and throat soreness with DMSO and citric acid |
DE4415553A1 (de) * | 1994-05-03 | 1995-11-09 | Behringwerke Ag | Verwendung von Deoxyspergualin zur Herstellung eines Arzneimittels zur Behandlung von entzündlich-hyperreaktiven Erkrankungen |
CA2253260A1 (en) * | 1996-05-02 | 1997-11-13 | Taisho Pharmaceutical Co., Ltd. | Suspension of sparingly water-soluble acidic drug |
DE19933148A1 (de) * | 1999-07-20 | 2001-01-25 | Boehringer Ingelheim Int | Ambroxolhaltige Lutschtablette |
JP2001151677A (ja) * | 1999-11-26 | 2001-06-05 | Taisho Pharmaceut Co Ltd | 咽頭用組成物 |
DE20102817U1 (de) * | 2000-02-23 | 2001-06-07 | Bolder Arzneimittel Gmbh | Lutsch- und Kaupastillen mit Cyclodextrin |
US6391886B1 (en) * | 2000-12-04 | 2002-05-21 | The Procter & Gamble Company | Oral compositions having improved consumer aesthetics |
-
2002
- 2002-02-27 DE DE10208313A patent/DE10208313A1/de not_active Withdrawn
-
2003
- 2003-02-25 UA UA20040907789A patent/UA86741C2/ru unknown
- 2003-02-25 KR KR10-2004-7013393A patent/KR20040084944A/ko active Search and Examination
- 2003-02-25 RU RU2004129284/15A patent/RU2311176C2/ru not_active IP Right Cessation
- 2003-02-25 CN CNA038047683A patent/CN1638749A/zh active Pending
- 2003-02-25 JP JP2003570840A patent/JP2005518435A/ja active Pending
- 2003-02-25 UY UY27679A patent/UY27679A1/es not_active Application Discontinuation
- 2003-02-25 WO PCT/EP2003/001886 patent/WO2003072094A1/de active Application Filing
- 2003-02-25 AU AU2003210345A patent/AU2003210345B2/en not_active Ceased
- 2003-02-25 MY MYPI20030651A patent/MY144781A/en unknown
- 2003-02-25 BR BR0308038-2A patent/BR0308038A/pt not_active Expired - Fee Related
- 2003-02-25 CA CA002477105A patent/CA2477105A1/en not_active Abandoned
- 2003-02-25 TW TW092103899A patent/TW200306804A/zh unknown
- 2003-02-25 PL PL03371584A patent/PL371584A1/xx not_active Application Discontinuation
- 2003-02-25 MX MXPA04008220A patent/MXPA04008220A/es not_active Application Discontinuation
- 2003-02-25 EP EP03742955A patent/EP1480626A1/de not_active Ceased
- 2003-02-26 AR ARP030100619A patent/AR038698A1/es not_active Suspension/Interruption
- 2003-02-26 PE PE2003000187A patent/PE20030830A1/es not_active Application Discontinuation
-
2004
- 2004-07-15 ZA ZA200405635A patent/ZA200405635B/en unknown
- 2004-08-19 IS IS7417A patent/IS7417A/is unknown
- 2004-08-20 EC EC2004005242A patent/ECSP045242A/es unknown
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11759439B2 (en) | 2017-06-16 | 2023-09-19 | Kai-Uwe KERN | Bromhexine for the treatment of pain |
Also Published As
Publication number | Publication date |
---|---|
DE10208313A1 (de) | 2003-09-11 |
ZA200405635B (en) | 2005-05-31 |
RU2004129284A (ru) | 2005-06-10 |
JP2005518435A (ja) | 2005-06-23 |
KR20040084944A (ko) | 2004-10-06 |
PE20030830A1 (es) | 2003-10-31 |
BR0308038A (pt) | 2004-12-28 |
WO2003072094A1 (de) | 2003-09-04 |
RU2311176C2 (ru) | 2007-11-27 |
UY27679A1 (es) | 2003-09-30 |
MXPA04008220A (es) | 2004-11-26 |
EP1480626A1 (de) | 2004-12-01 |
AU2003210345A1 (en) | 2003-09-09 |
TW200306804A (en) | 2003-12-01 |
PL371584A1 (en) | 2005-06-27 |
UA86741C2 (ru) | 2009-05-25 |
MY144781A (en) | 2011-11-15 |
AR038698A1 (es) | 2005-01-26 |
IS7417A (is) | 2004-08-19 |
ECSP045242A (es) | 2004-09-28 |
CN1638749A (zh) | 2005-07-13 |
AU2003210345B2 (en) | 2009-01-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20100330176A1 (en) | Ambroxol for the treatment of painful conditions in the mouth and pharyngeal cavity | |
US20140079740A1 (en) | Oral transmucosal adminstration forms of s-ketamine | |
US20090263467A1 (en) | Combination drug therapy using orally dissolving film or orally disintegrating tablet dosage forms to treat dry mouth ailments | |
AU2003210345B2 (en) | Ambroxol for treating painful conditions in the mouth and pharyngeal cavity | |
WO2007143676A2 (en) | Epinephrine dosing regimens comprising buccal, lingual or sublingual and injectable dosage forms | |
KR20050120753A (ko) | 경점막 약물 전달 시스템 | |
WO2008095284A1 (en) | Fast-disintegrating epinephrine tablets for buccal or sublingual administration | |
MXPA03007081A (es) | Medicamento de accion rapida para el tratamiento de disfuncion sexual. | |
US6297240B1 (en) | Method for treating ophthalmic disease through fast dispersing dosage forms | |
JP2000095675A (ja) | 口中溶解型又は咀嚼型鼻炎治療用固形内服医薬組成物 | |
JP2023545372A (ja) | デクスメデトミジン塩酸塩を用いた双極性障害及び精神病の治療 | |
JP2022132446A (ja) | 低中毒性抗コリン作動性エステルのための方法および組成物 | |
MXPA06009094A (es) | Formulaciones de liberacion controlada. | |
EP0315332B1 (en) | Antitussive liquid compositions containing phenol | |
CN101048149A (zh) | 口腔内溶解用固体制剂 | |
WO2023049262A1 (en) | Composition and method for prevention and treatment of cutaneous radiation injury | |
EP4363057A1 (en) | Methods for treating depressive states | |
CN100548281C (zh) | 用于递送催眠药穿过口腔粘膜的组合物及其用法 | |
KR20200131913A (ko) | 플루르비프로펜을 포함하는 약학적 조성물 | |
CA2840521C (en) | Pharmaceutical composition for treating premature ejaculation and method for treating premature ejaculation | |
US20160067187A1 (en) | Methods for Treating or Preventing Migraines | |
WO2024064898A2 (en) | Composition and method for prevention and treatment of cutaneous radiation injury | |
CN117750956A (zh) | 用于治疗抑郁状态的方法 | |
JP2023526337A (ja) | 口腔咽頭真菌感染症を処置するための粘膜付着錠 | |
CA3098302A1 (en) | Methods of treating bacterial infections with minocycline |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Discontinued |